Parametric Portfolio Associates’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $101K | Buy |
14,942
+24
| +0.2% | +$162 | ﹤0.01% | 3560 |
|
|
2021
Q4 | $125K | Buy |
14,918
+546
| +4% | +$4.58K | ﹤0.01% | 3520 |
|
|
2021
Q3 | $107K | Buy |
14,372
+2,793
| +24% | +$20.8K | ﹤0.01% | 3528 |
|
|
2021
Q2 | $79K | Sell |
11,579
-208
| -2% | -$1.42K | ﹤0.01% | 3502 |
|
|
2021
Q1 | $121K | Sell |
11,787
-473
| -4% | -$4.86K | ﹤0.01% | 3951 |
|
|
2020
Q4 | $86K | Sell |
12,260
-1,014
| -8% | -$7.11K | ﹤0.01% | 3897 |
|
|
2020
Q3 | $108K | Sell |
13,274
-19,201
| -59% | -$156K | ﹤0.01% | 3782 |
|
|
2020
Q2 | $224K | Buy |
32,475
+15,497
| +91% | +$107K | ﹤0.01% | 3593 |
|
|
2020
Q1 | $81K | Sell |
16,978
-1,626
| -9% | -$7.76K | ﹤0.01% | 3764 |
|
|
2019
Q4 | $162K | Sell |
18,604
-2,158
| -10% | -$18.8K | ﹤0.01% | 3783 |
|
|
2019
Q3 | $69K | Buy |
20,762
+1,915
| +10% | +$6.36K | ﹤0.01% | 3878 |
|
|
2019
Q2 | $93K | Sell |
18,847
-2,417
| -11% | -$11.9K | ﹤0.01% | 3850 |
|
|
2019
Q1 | $132K | Buy |
21,264
+9,488
| +81% | +$58.9K | ﹤0.01% | 3778 |
|
|
2018
Q4 | $40K | Buy |
+11,776
| New | +$40K | ﹤0.01% | 3864 |
|
|
2018
Q3 | – | Sell |
-46,230
| Closed | -$354K | – | 3980 |
|
|
2018
Q2 | $354K | Buy |
+46,230
| New | +$354K | ﹤0.01% | 3491 |
|